Alkermes Plc - ALKS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Alkermes Plc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
ALKS	Nasdaq	8731	http://a.alkermes.com/	31.69 +1.36
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Alkermes Plc Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 - May 16th, 2013 2:00 pm SGEN's Adcetris under FDA Review - May 16th, 2013 1:30 pm Alkermes Elects Nancy Wysenski to Board of Directors - May 16th, 2013 5:00 am ALKERMES PLC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - May 15th, 2013 11:01 pm Cempra/Toyama Ink Deal - May 15th, 2013 2:50 pm Much Awaited Test Launch by Genomic - May 15th, 2013 12:30 pm Myriad Soars Higher on Celeb Clout - May 15th, 2013 12:00 pm Isis Gets $3.5M Milestone Payment - May 14th, 2013 1:30 pm SALT 2013: The 5 Best Ideas of the Year Ahead - May 10th, 2013 2:58 pm 6 Superstars For Your Biotech Portfolio: John McCamant - May 10th, 2013 12:57 pm Alkermes' CEO Presents at Bank of America Merrill Lynch Smid Cap Conference (Transcript) - May 8th, 2013 1:31 pm Learn Which Antibody Companies Show Show a Higher Probability of Success; Antibodies Have a Higher Track Record of M&A and More Predictable Toxicology Profile - May 3rd, 2013 10:09 am Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference - May 1st, 2013 2:00 pm BioMarin Widens Loss, Maintains View - Apr 29th, 2013 9:00 am Stocks Pull Back Late Session; Apple, Panera Earnings On Tap - Apr 23rd, 2013 1:06 pm Illumina Beats on Earnings, Revenue - Apr 23rd, 2013 1:00 pm Health stocks ride potential, momentum to a higher close - Apr 22nd, 2013 8:36 am Alkermes downgraded to Neutral from Buy at Lazard Capital - Apr 22nd, 2013 5:14 am 5 of Last Week's Biggest Winners - Apr 21st, 2013 3:30 am This Week in Biotech: Part 2 - Apr 20th, 2013 10:35 am View All Current Headlines >>